Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2025-01-16 Purchase | 2025-01-21 5:34 pm | Zymeworks Inc. | ZYME | EcoR1 Capital LLC Director 10% Owner | 141,429 | $13.88 | $1,963,538 | 15,720,161 (Indirect) | View |
2025-01-13 Purchase | 2025-01-15 6:12 pm | Zymeworks Inc. | ZYME | EcoR1 Capital LLC Director 10% Owner | 167,654 | $13.59 | $2,278,811 | 15,578,732 (Indirect) | View |
2025-01-08 Purchase | 2025-01-10 6:27 pm | Zymeworks Inc. | ZYME | EcoR1 Capital LLC Director 10% Owner | 225,119 | $13.21 | $2,974,819 | 15,411,078 (Indirect) | View |
2025-01-06 Sale | 2025-01-06 8:35 pm | Zymeworks Inc. | ZYME | Moore Paul Andrew Chief Scientific Officer | 21,200 | $14.92 | $316,391 | 80,501 (Direct) | View |
2025-01-06 Sale | 2025-01-06 8:34 pm | Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO | 57,291 | $14.92 | $855,017 | 261,805 (Direct) | View |
2025-01-06 Sale | 2025-01-06 8:19 pm | Zymeworks Inc. | ZYME | Smith Jeffrey T L EVP & Chief Medical Officer | 11,110 | $14.92 | $165,807 | 48,890 (Direct) | View |
2024-12-30 Purchase | 2025-01-02 5:51 pm | Zymeworks Inc. | ZYME | EcoR1 Capital LLC Director 10% Owner | 363,369 | $14.64 | $5,321,176 | 15,185,959 (Indirect) | View |
2024-12-24 Purchase | 2024-12-27 6:41 pm | Zymeworks Inc. | ZYME | EcoR1 Capital LLC Director 10% Owner | 130,309 | $14.44 | $1,882,115 | 14,822,590 (Indirect) | View |
2024-12-19 Purchase(A) | 2024-12-26 12:46 pm | Zymeworks Inc. | ZYME | EcoR1 Capital LLC Director 10% Owner | 1,254,808 | $13.98 | $17,544,284 | 14,692,281 (Indirect) | View |
2024-01-05 Sale | 2024-01-08 6:23 pm | Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO | 23,904 | $10.79 | $257,845 | 619,096 (Direct) | View |
2024-01-05 Sale | 2024-01-08 6:14 pm | Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer | 5,994 | $10.79 | $64,656 | 107,503 (Direct) | View |
2024-01-05 Sale | 2024-01-08 6:01 pm | Zymeworks Inc. | ZYME | Moore Paul Andrew Chief Scientific Officer | 9,799 | $10.79 | $105,699 | 191,701 (Direct) | View |
2023-12-11 Sale | 2023-12-11 8:00 pm | Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer | 886 | $9.1301 | $8,089 | 1,997 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2025-01-10 Option Award | 2025-01-10 6:11 pm | N/A 2035-01-09 | Zymeworks Inc. | ZYME | PATTERSON LEONE D EVP, Chief Bus & Fin Officer | 132,000 | $0 | 132,000 (Direct) | View |
2025-01-10 Option Award | 2025-01-10 6:07 pm | N/A 2035-01-09 | Zymeworks Inc. | ZYME | Moore Paul Andrew Chief Scientific Officer | 132,000 | $0 | 132,000 (Direct) | View |
2025-01-10 Option Award | 2025-01-10 6:03 pm | N/A 2035-01-09 | Zymeworks Inc. | ZYME | Smith Jeffrey T L EVP & Chief Medical Officer | 132,000 | $0 | 132,000 (Direct) | View |
2025-01-10 Option Award | 2025-01-10 5:58 pm | N/A 2035-01-09 | Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO | 480,000 | $0 | 480,000 (Direct) | View |
2025-01-06 Exercise | 2025-01-06 8:35 pm | N/A N/A | Zymeworks Inc. | ZYME | Moore Paul Andrew Chief Scientific Officer | 37,166 | $0 | 80,501 (Direct) | View |
2025-01-06 Exercise | 2025-01-06 8:34 pm | N/A N/A | Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO | 114,332 | $0 | 261,805 (Direct) | View |
2025-01-06 Exercise | 2025-01-06 8:19 pm | N/A N/A | Zymeworks Inc. | ZYME | Smith Jeffrey T L EVP & Chief Medical Officer | 20,000 | $0 | 48,890 (Direct) | View |
2024-12-10 Option Award | 2024-12-12 6:20 pm | N/A 2034-12-09 | Zymeworks Inc. | ZYME | Miller Derek John Michael Director | 31,000 | $0 | 31,000 (Direct) | View |
2024-12-10 Option Award | 2024-12-12 6:15 pm | N/A 2034-12-09 | Zymeworks Inc. | ZYME | Campoy Carlos Director | 31,000 | $0 | 31,000 (Direct) | View |
2024-12-10 Option Award | 2024-12-12 6:01 pm | N/A 2034-12-09 | Zymeworks Inc. | ZYME | Cesano Alessandra Director | 31,000 | $0 | 31,000 (Direct) | View |
2024-12-10 Option Award | 2024-12-12 5:56 pm | N/A 2034-12-09 | Zymeworks Inc. | ZYME | Neu Kelvin Director | 31,000 | $0 | 31,000 (Direct) | View |
2024-12-10 Option Award | 2024-12-12 5:52 pm | N/A 2034-12-09 | Zymeworks Inc. | ZYME | Davidson Nancy Director | 31,000 | $0 | 31,000 (Direct) | View |
2024-12-10 Option Award | 2024-12-12 5:52 pm | N/A 2034-12-09 | Zymeworks Inc. | ZYME | Cox Troy Director | 31,000 | $0 | 31,000 (Direct) | View |
2024-12-10 Option Award | 2024-12-12 5:51 pm | N/A 2034-12-09 | Zymeworks Inc. | ZYME | Mahony Susan Director | 31,000 | $0 | 31,000 (Direct) | View |
2024-12-10 Option Award | 2024-12-12 5:49 pm | N/A 2034-12-09 | Zymeworks Inc. | ZYME | Gallagher Neil Director | 31,000 | $0 | 31,000 (Direct) | View |
2024-09-01 Option Award | 2024-09-03 5:50 pm | N/A 2034-08-31 | Zymeworks Inc. | ZYME | PATTERSON LEONE D EVP, Chief Bus & Fin Officer | 360,000 | $0 | 360,000 (Direct) | View |
Ownership | 2024-09-03 5:45 pm | N/A N/A | Zymeworks Inc. | ZYME | PATTERSON LEONE D EVP, Chief Bus & Fin Officer | 0 | $0 | 0 (Direct) | View |
2024-04-02 Option Award | 2024-04-02 9:54 pm | N/A 2034-04-01 | Zymeworks Inc. | ZYME | Gallagher Neil Director | 74,000 | $0 | 74,000 (Direct) | View |
Ownership | 2024-04-02 9:52 pm | N/A N/A | Zymeworks Inc. | ZYME | Gallagher Neil Director | 0 | $0 | 0 (Direct) | View |
2024-02-08 Option Award | 2024-02-09 6:15 pm | N/A 2034-02-07 | Zymeworks Inc. | ZYME | Cesano Alessandra Director | 74,000 | $0 | 74,000 (Direct) | View |
Ownership | 2024-02-09 6:00 pm | N/A N/A | Zymeworks Inc. | ZYME | Cesano Alessandra Director | 0 | $0 | 0 (Direct) | View |
2024-01-05 Exercise | 2024-01-08 6:23 pm | N/A N/A | Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO | 47,666 | $0 | 619,096 (Direct) | View |
2024-01-05 Option Award | 2024-01-08 6:23 pm | N/A 2034-01-04 | Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO | 500,000 | $0 | 619,096 (Direct) | View |
2024-01-05 Exercise | 2024-01-08 6:14 pm | N/A N/A | Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer | 10,500 | $0 | 107,503 (Direct) | View |
2024-01-05 Option Award | 2024-01-08 6:14 pm | N/A 2034-01-04 | Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer | 80,000 | $0 | 107,503 (Direct) | View |
2024-01-05 Exercise | 2024-01-08 6:01 pm | N/A N/A | Zymeworks Inc. | ZYME | Moore Paul Andrew Chief Scientific Officer | 17,166 | $0 | 191,701 (Direct) | View |
2024-01-05 Option Award | 2024-01-08 6:01 pm | N/A 2034-01-04 | Zymeworks Inc. | ZYME | Moore Paul Andrew Chief Scientific Officer | 150,000 | $0 | 191,701 (Direct) | View |
2024-01-05 Option Award | 2024-01-08 6:00 pm | N/A 2034-01-04 | Zymeworks Inc. | ZYME | Smith Jeffrey T L EVP & Chief Medical Officer | 150,000 | $0 | 150,000 (Direct) | View |
Ownership | 2024-01-05 6:00 pm | N/A N/A | Zymeworks Inc. | ZYME | Smith Jeffrey T L EVP & Chief Medical Officer | 0 | $0 | 188,000 (Direct) | View |
2023-12-11 Exercise | 2023-12-11 8:00 pm | N/A N/A | Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer | 1,550 | $0 | 1,997 (Direct) | View |
2023-12-07 Option Award | 2023-12-08 5:48 pm | N/A 2033-12-06 | Zymeworks Inc. | ZYME | Campoy Carlos Director | 37,000 | $0 | 37,000 (Direct) | View |
2023-12-07 Option Award | 2023-12-08 5:41 pm | N/A 2033-12-06 | Zymeworks Inc. | ZYME | RENTON HOLLINGS Director | 37,000 | $0 | 37,000 (Direct) | View |
2023-12-07 Option Award | 2023-12-08 5:26 pm | N/A 2033-12-06 | Zymeworks Inc. | ZYME | Neu Kelvin Director | 37,000 | $0 | 37,000 (Direct) | View |
2023-12-07 Option Award | 2023-12-08 5:26 pm | N/A 2033-12-06 | Zymeworks Inc. | ZYME | Cox Troy Director | 37,000 | $0 | 37,000 (Direct) | View |